Real-world bone turnover marker use: impact on treatment decisions and fracture.
Nancy E LaneKenneth G SaagT J O'NeillM ManionRoma ShahU KlauseRichard EastellPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2020)
In this large, heterogeneous population of patients with presumed osteoporosis, BTM testing was associated with treatment decision-making, likely leading to fragility fracture reduction following use.